Vietnam MOH registration 220001460/PCBB-HCM

Drugs used for HbA1c quantitative testing

VN: Thuốc thử dùng cho xét nghiệm định lượng HbA1c

Vietnam·Risk Class TTBYT Loại B·HbA1c (Glycated Hemoglobin) Rapid Quantitative Test (Immunofluorescence Assay)·Aehealth Limited·Registered May 04, 2022

Registration details

Analysis ID: 220001460/PCBB-HCM
Submission ID: 000.00.19.H29-220423-0010
Product Type: HbA1c (Glycated Hemoglobin) Rapid Quantitative Test (Immunofluorescence Assay)

Company information

Manufacturer: Aehealth Limited

Technical details

Intended Use: Used for the quantification of HbA1c in the whole blood. Used to monitor diabetes

Dates and status

Registration Date: May 04, 2022

About this record

Access comprehensive regulatory information for Drugs used for HbA1c quantitative testing in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 220001460/PCBB-HCM and manufactured by Aehealth Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.